Login / Signup

Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.

Wanlu MaWei BaiXueyan WuJiu-Liang ZhaoMeng Tao LiXiaofeng Zeng
Published in: Lupus (2020)
Our cases confirmed the efficacy and good follow-up outcomes of low-dose rituximab treatment (100 mg weekly for 4 weeks) for refractory SLE-TTP.
Keyphrases
  • low dose
  • systemic lupus erythematosus
  • diffuse large b cell lymphoma
  • disease activity
  • high dose
  • hodgkin lymphoma
  • rheumatoid arthritis
  • gestational age
  • weight loss